FDA issues new policy on remote monitoring devices for use during COVID-19 pandemic

Mar 20, 2020 | Cardiac Rhythm News

The US Food and Drug Administration (FDA) has issued an immediately-in-effect guidance that allows manufacturers of certain FDA-cleared non-invasive, vital-sign-measuring devices to expand their use so that health care providers can use them to monitor patients remotely.